TEMPE, Ariz., March 5, 2010 (GLOBE NEWSWIRE) -- Capstone Therapeutics (the “Company”) (Nasdaq:CAPS) today announced it received a letter on March 4, 2010 from The Nasdaq Stock Market notifying the Company that it is now in compliance with the Nasdaq Listing Rules for continued listing on The Nasdaq Capital Market.
